Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection?
Baxter
G F
GF
Hatter Institute for Cardiovascular Studies, Department of Academic and Clinical Cardiology, University College London Hospitals.
Yellon
D M
DM
D015906:Angioplasty, Balloon, Coronary; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000517:prevention & control; D003131:Combined Modality Therapy; D003328:Coronary Thrombosis / Q000188:drug therapy; D006321:Heart / Q000187:drug effects / Q000502:physiology; D006801:Humans; D066298:In Vitro Techniques; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D017202:Myocardial Ischemia / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D015427:Reperfusion Injury / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy
D000925:Anticoagulants